Compare Natera Inc. Common Stock (NTRA) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Star Bulk Carriers Corp — how do they compare? Natera Inc. Common Stock trades at $401.69 (market cap $57.03B), while Star Bulk Carriers Corp trades at $28.01 (market cap $3.34B). The key difference: Natera Inc. Common Stock is far larger — about 17.1× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 6.53% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Star Bulk Carriers Corp for 23 Days on average.
| NTRA | SBLK | |
|---|---|---|
Market Cap | $57.03B | $3.34B |
Volume | 1,131,157 | 1,935,552 |
Sector | Health | Industrials |
52-Week High | $425.64 | $32.49 |
52-Week Low | $179.42 | $17.42 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $56.18B | $4.02B |
Dividend Yield | — | 6.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Star Bulk Carriers (SBLK) is trading at $28.28, down 5.07% today, with a bearish technical signal but strong fundamental performance. The company has beaten earnings estimates for three consecutive quarters, maintains a P/E of 11.28, and offers a $0.90 dividend. Recent insider buying and positive analyst coverage (58% buy ratings) contrast with the current technical weakness, creating a potential value opportunity.
SBLK presents a compelling value proposition with attractive valuation metrics and consistent earnings outperformance. Key risks include shipping market volatility and the stock's current technical downtrend. The combination of strong fundamentals, dividend yield, and insider confidence suggests potential for recovery despite near-term price pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
